Extracellular PKM2 Preserves Cardiomyocytes and Reduces Cardiac Fibrosis During Myocardial Infarction

Yang Huang, Bin Li, Zongxiang Gui, Erhe Gao, Yi Yuan, Jenny Yang, Khan Hekmatyar, Falguni Mishra, Payton Chan, Zhiren Liu · 2024

Read Extracellular PKM2 Preserves Cardiomyocytes and Reduces Cardiac Fibrosis During Myocardial Infarction by Yang Huang, Bin Li, Zongxiang Gui, Erhe Gao, Yi Yuan, Jenny Yang, Khan Hekmatyar, Falguni Mishra, Payton Chan, Zhiren Liu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11675365.txt.

Description

Yang Huang and co-authors present a 2024 study on protecting heart muscle during a heart attack. Losing heart cells is the main reason heart attacks kill or disable, and no current treatment directly prevents that loss. The team tested a modified version of a metabolic protein, PKM2, given to the whole body rather than acting inside cells.

The altered protein, called G415R, docked onto a receptor on heart cells and switched on survival signals. Treated animals kept more heart cells alive, grew some new ones, and developed less scarring because scar-forming cells stayed quieter. The protein worked even under low oxygen and chemical stress in lab tests. The authors propose it as a candidate therapy for heart attacks and related disease.

Catalog record

CREATORYang Huang, Bin Li, Zongxiang Gui, Erhe Gao, Yi Yuan, Jenny Yang, Khan Hekmatyar, Falguni Mishra, Payton Chan, Zhiren Liu
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE36 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11675365

Browse the full library · About the Tower of Babel